Santen Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 30, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	2,861	2,991	3,427	2,938	3,639	4,690
Market Cap Growth	-14.50%	-12.73%	16.63%	-19.26%	-22.41%	-25.27%
Enterprise Value	2,508	2,505	2,920	2,510	3,132	4,279
Last Close Price	9.25	8.55	8.69	7.17	8.00	10.72
PE Ratio	15.81	13.35	21.00	-	18.04	89.19
PS Ratio	1.70	1.61	1.85	1.52	1.84	2.44
PB Ratio	1.82	1.70	1.83	1.45	1.46	1.98
P/TBV Ratio	2.52	2.30	2.52	2.15	2.37	3.13
P/FCF Ratio	12.80	8.92	8.83	21.36	17.11	17.56
P/OCF Ratio	10.75	7.95	7.70	11.42	10.66	15.69
EV/Sales Ratio	1.58	1.35	1.58	1.30	1.59	2.23
EV/EBITDA Ratio	7.70	6.12	6.77	6.90	7.98	7.90
EV/EBIT Ratio	11.04	8.39	9.13	10.27	11.78	10.38
EV/FCF Ratio	11.22	7.47	7.52	18.24	14.72	16.02
Debt / Equity Ratio	-	0.12	0.11	0.12	0.10	0.03
Debt / EBITDA Ratio	-	0.52	0.49	0.69	0.62	0.14
Debt / FCF Ratio	-	0.63	0.55	1.82	1.15	0.29
Asset Turnover	0.73	0.71	0.71	0.63	0.62	0.62
Inventory Turnover	2.25	2.72	2.99	2.95	2.79	2.56
Quick Ratio	1.72	1.90	2.00	1.85	1.91	2.02
Current Ratio	2.65	2.58	2.55	2.38	2.39	2.63
Return on Equity (ROE)	11.04%	12.14%	8.92%	-4.75%	8.45%	2.18%
Return on Assets (ROA)	6.63%	7.14%	7.61%	5.01%	5.20%	8.25%
Return on Invested Capital (ROIC)	15.68%	15.46%	18.05%	12.64%	10.12%	11.99%
Return on Capital Employed (ROCE)	13.40%	15.00%	15.20%	10.60%	9.90%	16.50%
Earnings Yield	6.32%	7.49%	4.76%	-3.52%	5.54%	1.12%
FCF Yield	7.82%	11.21%	11.33%	4.68%	5.85%	5.70%
Dividend Yield	2.45%	2.60%	2.33%	3.09%	2.96%	2.01%
Payout Ratio	39.53%	33.40%	44.59%	-	44.07%	163.81%
Buyback Yield / Dilution	5.30%	5.01%	4.98%	3.26%	-0.02%	-0.03%
Total Shareholder Return	7.75%	7.61%	7.30%	6.35%	2.95%	1.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.